Cell line name |
Rj2.2.5 |
Synonyms |
RJ2.2.5; RJ-2.2.5; RJ 2.2.5; RJ2.25; Raji 2.2.5 |
Accession |
CVCL_3414 |
Resource Identification Initiative |
To cite this cell line use: Rj2.2.5 (RRID:CVCL_3414) |
Comments |
Population: African; Nigerian. Characteristics: Deficient in expression of HLA class II antigens. Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Transformant: NCIt; C44386; Gamma radiation. Omics: H3K27ac ChIP-seq epigenome analysis. Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397. Cell type: B-cell; CL=CL_0000236. |
Sequence variations |
- Gene deletion; HGNC; 7067; CIITA; Zygosity=Heterozygous (PubMed=8402893).
- Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line).
- Mutation; HGNC; 7067; CIITA; Unexplicit; Major internal deletion; Zygosity=Heterozygous (PubMed=8402893).
- Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
|
HLA typing |
Source: CLS=300360
Class I | HLA-A | A*03:01:01 | HLA-B | B*15:10:01 | HLA-C | C*03:04:02,04:01:01 | Class II | HLA-DP | DPB1*01:01:01 | HLA-DQ | DQA1*01:05:01,05:01:01 | | DQB1*02:01:01,05:01:01 | HLA-DR | DRB1*03:01:01,10:01:01 |
|
Disease |
EBV-related Burkitt lymphoma (NCIt: C27694) Burkitt lymphoma (ORDO: Orphanet_543) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Hierarchy |
Parent: CVCL_0511 (Raji) |
Sex of cell |
Male |
Age at sampling |
11Y |
Category |
Cancer cell line |
STR profile |
Source(s): CLS=300360
Markers:Amelogenin | X,Y |
CSF1PO | 10,12 |
D3S1358 | 15,16 |
D5S818 | 10 |
D7S820 | 10 |
D8S1179 | 14,15 |
D13S317 | 13 |
D16S539 | 8,11 |
D18S51 | 17 |
D21S11 | 28,31 |
FGA | 19,27 |
Penta D | 3.2,9 |
Penta E | 5,13 |
TH01 | 6,7 |
TPOX | 8,13 |
vWA | 16,19 |
Run an STR similarity search on this cell line |
Web pages |
https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-28.html https://emoryott.technologypublisher.com/tech/CIITA_Deficient_Human_B_Cell_Line |
Publications | PubMed=6403646; DOI=10.1084/jem.157.3.1053; PMCID=PMC2186959 Accolla R.S. Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J. Exp. Med. 157:1053-1058(1983) PubMed=2511169; DOI=10.1016/0198-8859(89)90007-4 Hume C.R., Lee J.S. Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors. Hum. Immunol. 26:288-309(1989) PubMed=1852002; DOI=10.1073/pnas.88.10.4285; PMCID=PMC51643 Benichou B., Strominger J.L. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. U.S.A. 88:4285-4288(1991) PubMed=1538137; DOI=10.4049/jimmunol.148.5.1576 Seidl C., Saraiya C., Osterweil Z., Fu Y.P., Lee J.S. Genetic complexity of regulatory mutants defective for HLA class II gene expression. J. Immunol. 148:1576-1584(1992) PubMed=8402893; DOI=10.1016/S0092-8674(05)80090-X Steimle V., Otten L.A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-146(1993) PubMed=8441650; DOI=10.1093/nar/21.3.381; PMCID=PMC309128 Ombra M.N., Perfetto C., Autiero M., Anzisi A.M., Pasquinelli R., Maffei A., Del Pozzo G., Guardiola J. Reversion of a transcriptionally defective MHC class II-negative human B-cell mutant. Nucleic Acids Res. 21:381-386(1993) |
Cross-references |
Cell line collections (Providers) |
CLS; 300360
ICLC; HTL02002
|
Cell line databases/resources |
CLDB; cl7125
cancercelllines; CVCL_3414
|
Encyclopedic resources |
Wikidata; Q54950516
|
Gene expression databases |
GEO; GSM1602239
GEO; GSM1602240
GEO; GSM1602245
GEO; GSM1602246
|
Entry history |
Entry creation | 04-Apr-2012 |
Last entry update | 02-May-2024 |
Version number | 24 |
---|